IPP Bureau
Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
By IPP Bureau - June 11, 2022
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Sanyou Biopharmaceuticals launches Super-Trillion Antibody Libraries
By IPP Bureau - June 11, 2022
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
AIkido Pharma appoints Soo Yu as Director
By IPP Bureau - June 11, 2022
New Director supports NASDAQ rule on diversity
Illumina appoints Joydeep Goswami as Interim CFO
By IPP Bureau - June 11, 2022
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
AeroSafe Global appointment Jessica Cao as Sr VP (Marketing)
By IPP Bureau - June 11, 2022
Company hires life science veteran Jessica Cao to join management team
Nippon Express launches ultra-low temperature-controlled service for pharma industry
By IPP Bureau - June 11, 2022
Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C
Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus
By IPP Bureau - June 10, 2022
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies
By IPP Bureau - June 10, 2022
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth
By IPP Bureau - June 10, 2022
The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).
Sanofi Dupixent gets USFDA nod for atopic dermatitis
By IPP Bureau - June 10, 2022
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
India's bio-economy has grown 8 times in the last 8 years: PM Modi
By IPP Bureau - June 10, 2022
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
GE Healthcare’s molecular imaging solutions enable precision health & theranostics for prostate cancer
By IPP Bureau - June 10, 2022
Healthcare is timely and personal – and its delivery should be too
Bayer’s Vividion emerging as significant player in San Diego Biotech hub
By IPP Bureau - June 10, 2022
Bayer now present in four of the largest biotechnology hubs in the United States
University of Glasgow opens Mazumdar Shaw Advance Research Centre
By IPP Bureau - June 10, 2022
The £118 million Mazumdar-Shaw Advanced Research Centre (ARC) will be the creative and collaborative heart of cross-disciplinary research at the University of Glasgow.
National Ayurveda Research Institute for Panchakarma bags NABL Accreditation
By IPP Bureau - June 09, 2022
A big boost to healthcare efforts of Ayush through NARIP, CCRAS
